434 related articles for article (PubMed ID: 8826969)
1. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
[TBL] [Abstract][Full Text] [Related]
2. Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes.
Kawasaki E; Yu L; Rewers MJ; Hutton JC; Eisenbarth GS
Diabetes; 1998 May; 47(5):733-42. PubMed ID: 9588444
[TBL] [Abstract][Full Text] [Related]
3. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2.
Hawkes CJ; Wasmeier C; Christie MR; Hutton JC
Diabetes; 1996 Sep; 45(9):1187-92. PubMed ID: 8772720
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
[TBL] [Abstract][Full Text] [Related]
5. ICA512 autoantibody radioassay.
Gianani R; Rabin DU; Verge CF; Yu L; Babu SR; Pietropaolo M; Eisenbarth GS
Diabetes; 1995 Nov; 44(11):1340-4. PubMed ID: 7589834
[TBL] [Abstract][Full Text] [Related]
6. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs.
Kawasaki E; Yu L; Gianani R; Verge CF; Babu S; Bonifacio E; Eisenbarth GS
J Clin Endocrinol Metab; 1997 Feb; 82(2):375-80. PubMed ID: 9024221
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
9. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of the human transmembrane protein tyrosine phosphatase homologue, phogrin, an autoantigen of type 1 diabetes.
Kawasaki E; Hutton JC; Eisenbarth GS
Biochem Biophys Res Commun; 1996 Oct; 227(2):440-7. PubMed ID: 8878534
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS
Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177
[TBL] [Abstract][Full Text] [Related]
12. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.
Passini N; Larigan JD; Genovese S; Appella E; Sinigaglia F; Rogge L
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9412-6. PubMed ID: 7568143
[TBL] [Abstract][Full Text] [Related]
13. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes.
Mayrhofer M; Rabin DU; Messenger L; Standl E; Ziegler AG
Exp Clin Endocrinol Diabetes; 1996; 104(3):228-34. PubMed ID: 8817240
[TBL] [Abstract][Full Text] [Related]
14. Cross reactivity between IA-2 and phogrin/IA-2beta in binding of autoantibodies in IDDM.
Hatfield EC; Hawkes CJ; Payton MA; Christie MR
Diabetologia; 1997 Nov; 40(11):1327-33. PubMed ID: 9389426
[TBL] [Abstract][Full Text] [Related]
15. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
16. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
17. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).
Payton MA; Hawkes CJ; Christie MR
J Clin Invest; 1995 Sep; 96(3):1506-11. PubMed ID: 7657822
[TBL] [Abstract][Full Text] [Related]
18. Cellular immune response to diverse islet cell antigens in IDDM.
Durinovic-Bellò I; Hummel M; Ziegler AG
Diabetes; 1996 Jun; 45(6):795-800. PubMed ID: 8635655
[TBL] [Abstract][Full Text] [Related]
19. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta.
Li Q; Borovitskaya AE; DeSilva MG; Wasserfall C; Maclaren NK; Notkins AL; Lan MS
Proc Assoc Am Physicians; 1997 Jul; 109(4):429-39. PubMed ID: 9220540
[TBL] [Abstract][Full Text] [Related]
20. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]